Peggy Peck

UROLOGY ASSOCIATES OF DOVER

200 BANNING ST

SUITE 250

Articles

AMA: After One-Year Increase, AMA Membership Declines Again

June 25, 2007

CHICAGO -- After a brief upward spike, the AMA's membership is shrinking again.

Pregabalin (Lyrica) Is First Drug Approved for Fibromyalgia

June 22, 2007

ROCKVILLE, Md. -- The FDA has approved pregabalin (Lyrica) for the treatment of fibromyalgia, making it the first drug to earn this indication.

Almost All U.S. Hospitals Meet Expectations for MI and Heart Failure Mortality

June 22, 2007

BALTIMORE -- Most of the 5,000 hospitals that care for Medicare patients meet the national average for 30-day mortality from MI or heart failure, Centers for Medicare & Medicaid Services (CMS) data show.

FDA Approves Ambrisentan (Letairis) for Pulmonary Arterial Hypertension

June 18, 2007

ROCKVILLE, Md. -- The FDA has approved ambrisentan (Letairis), an endothelin receptor antagonist, for treatment of pulmonary arterial hypertension (PAH).

AAICPD: More than 100 Million Alzheimer's Patients Predicted Worldwide by 2050

June 11, 2007

WASHINGTON -- The worldwide prevalence of Alzheimer's disease, estimated at 26.6 million patients, may quadruple by 2050, according to a mathematical model.

ASCO: Evolving Targeted Therapies in Lung Cancer

June 05, 2007

CHICAGO -- The success of targeted therapies in lung cancer depends not only on identifying the correct molecular target, but also on targeting patients who are likely responders, oncologists here said.

Drug-Maker Defends Rosiglitazone in Letter to The Lancet

May 30, 2007

KING OF PRUSSIA, Pa. -- Despite reports linking rosiglitazone (Avandia) to increased risk of cardiac events, the data safety monitoring boards assessing that risk in three studies of the drug agreed that the trials should continue.

Contact Lens Solution Recalled Over Link With Acanthamoeba Keratitis

May 29, 2007

ROCKVILLE, Md., May 29 -- A possible parasitic contamination of a solution for soft contact lens wearers has triggered a national recall.

At the Center of Rosiglitazone Storm, Steven Nissen, M.D., Focuses on Safety

May 25, 2007

CLEVELAND, May 25 -- Steven E. Nissen, M.D., a cardiologist best known for exposing heart risks in the medicine chest, has a message for the pharmaceutical industry, "I'm not anti-drug."

IOM Recommends FDA Regulation of Tobacco Products

May 24, 2007

WASHINGTON -- The FDA should be given the authority to regulate tobacco as an addictive drug, including marketing, advertising, and, eventually, the right to regulate nicotine content, said an Institute of Medicine report issued today.